Injection, Suspension

Human Papillomavirus 9-Valent Vaccine, Recombinant

Human Papillomavirus Type 11 L1 Capsid Protein Antigen + Human Papillomavirus Type 16 L1 Capsid Protein Antigen + Human Papillomavirus Type 18 L1 Capsid Protein Antigen + Human Papillomavirus Type 31 L1 Capsid Protein Antigen + Human Papillomavirus Type 33 L1 Capsid Protein Antigen + Human Papillomavirus Type 45 L1 Capsid Protein Antigen + Human Papillomavirus Type 52 L1 Capsid Protein Antigen + Human Papillomavirus Type 58 L1 Capsid Protein Antigen + Human Papillomavirus Type 6 L1 Capsid Protein Antigen

1 ACTIVE SUPPLIER — US

openFDA · updated weekly

US2 NDCs
1 active makers

UKComing
soon

CAComing
soon

AUComing
soon

EUComing
soon

ATC—

RxCUI (US)—

US makers1 labelers

Packages2

DEA / ScheduleNone

Medicaid dispensing volume

No Medicaid utilization on record for this drug concept yet. Quarterly volume (CMS State Drug Utilization Data) loads with the utilization ETL.

Who makes it1 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

Labeler	Type	Packages	Status
MSD Ireland (Carlow)	unknown	2	SUPPLYING

Regulatory & supply events

No recalls, shortages, or registration changes on record for this drug concept.